{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:08:10Z","timestamp":1791112090102,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,10,26]],"date-time":"2006-10-26T00:00:00Z","timestamp":1161820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2006,10,26]],"date-time":"2006-10-26T00:00:00Z","timestamp":1161820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ank is a multipass transmembrane protein that regulates the cellular transport of inorganic pyrophosphate. In the progressive ankylosis (<jats:italic>ank<\/jats:italic>) mouse, a premature termination mutation at glutamic acid 440 results in a phenotype characterized by inappropriate deposition of basic calcium phosphate crystals in skeletal tissues. Mutations in the amino terminus of ANKH, the human homolog of Ank, result in familial calcium pyrophosphate dihydrate deposition disease. It has been hypothesized that these mutations result in a gain-of-function with respect to the elaboration of extracellular inorganic pyrophosphate. To explore this issue in a mineralization-competent system, we stably transduced ATDC5 cells with wild-type Ank as well as with familial chondrocalcinosis-causing Ank mutations. We evaluated the elaboration of inorganic pyrophosphate, the activity of pyrophosphate-modulating enzymes, and the mineralization in the transduced cells. Expression of transduced protein was confirmed by quantitative real-time PCR and by ELISA. Levels of inorganic pyrophosphate were measured, as were the activities of nucleotide pyrophosphatase phosphodiesterase and alkaline phosphatase. We also evaluated the expression of markers of chondrocyte maturation and the nature of the mineralization phase elaborated by transduced cells. The cell line expressing the proline to leucine mutation at position 5 (P5L) consistently displayed higher levels of extracellular inorganic pyrophosphate and higher phosphodiesterase activity than the other transduced lines. During hypertrophy, however, extracellular inorganic pyrophosphate levels were modulated by alkaline phosphatase activity in this cell system, resulting in the deposition of basic calcium phosphate crystals only in all transduced cell lines. Cells overexpressing wild-type Ank displayed a higher level of expression of type X collagen than cells transduced with mutant Ank. Other markers of hypertrophy and terminal differentiation, such as alkaline phosphatase, osteopontin, and <jats:italic>runx2<\/jats:italic>, were not significantly different in cells expressing wild-type or mutant Ank in comparison with cells transduced with an empty vector or with untransduced cells. These results suggest that the P5L Ank mutant is capable of demonstrating a gain-of-function with respect to extracellular inorganic pyrophosphate elaboration, but this effect is modified by high levels of expression of alkaline phosphatase in ATDC5 cells during hypertrophy and terminal differentiation, resulting in the deposition of basic calcium phosphate crystals.<\/jats:p>","DOI":"10.1186\/ar2072","type":"journal-article","created":{"date-parts":[[2006,10,26]],"date-time":"2006-10-26T18:16:43Z","timestamp":1161886603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["P5L mutation in Ank results in an increase in extracellular inorganic pyrophosphate during proliferation and nonmineralizing hypertrophy in stably transduced ATDC5 cells"],"prefix":"10.1186","volume":"8","author":[{"given":"Raihana","family":"Zaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold S","family":"Dion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kusnierz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene J","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,10,26]]},"reference":[{"key":"1937_CR1","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/00002281-200305000-00023","volume":"15","author":"CJ Williams","year":"2003","unstructured":"Williams CJ: Familial calcium pyrophosphate dihydrate deposition disease and the ANKH gene [review, 43 refs]. Curr Opin Rheumatol. 2003, 15: 326-331. 10.1097\/00002281-200305000-00023.","journal-title":"Curr Opin Rheumatol"},{"key":"1937_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1126\/science.289.5477.265","volume":"289","author":"AM Ho","year":"2000","unstructured":"Ho AM, Johnson MD, Kingsley DM: Role of the mouse ank gene in control of tissue calcification and arthritis.[see comment]. Science. 2000, 289: 265-270. 10.1126\/science.289.5477.265.","journal-title":"Science"},{"key":"1937_CR3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1053\/joca.2002.0810","volume":"10","author":"P Sohn","year":"2002","unstructured":"Sohn P, Crowley M, Slattery E, Serra R: Developmental and TGF-\u03b2 mediated regulation of Ank mRNA expression in cartilage and bone. Osteoarthritis Cartilage. 2002, 10: 482-490. 10.1053\/joca.2002.0810.","journal-title":"Osteoarthritis Cartilage"},{"key":"1937_CR4","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1002\/art.10632","volume":"46","author":"J Hirose","year":"2002","unstructured":"Hirose J, Ryan LM, Masuda I: Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum. 2002, 46: 3218-3229. 10.1002\/art.10632.","journal-title":"Arthritis Rheum"},{"key":"1937_CR5","doi-asserted-by":"publisher","first-page":"S247","DOI":"10.1002\/art.11486","volume":"50","author":"M Uzuki","year":"2004","unstructured":"Uzuki M, Ryan LM, Sawai T, Kingsley DM, Masuda I: Up-regulated expression of ANK in joint tissue from patients with calcium pyrophosphate dihydrate crystal deposition disease (CPPD) [abstract]. Arthritis Rheum. 2004, 50: S247-10.1002\/art.11486.","journal-title":"Arthritis Rheum"},{"key":"1937_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.joca.2003.12.004","volume":"12","author":"K Johnson","year":"2004","unstructured":"Johnson K, Terkeltaub R: Upregulated ank expression in osteoarthritis can promote both chondrocyte MMP-13 expression and calcification via chondrocyte extracellular PPi excess. Osteoarthritis Cartilage. 2004, 12: 321-335. 10.1016\/j.joca.2003.12.004.","journal-title":"Osteoarthritis Cartilage"},{"key":"1937_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1128\/MCB.25.1.312-323.2005","volume":"25","author":"W Wang","year":"2005","unstructured":"Wang W, Xu J, Du B, Kirsch T: Role of the progressive ankylosis gene (ank) in cartilage mineralization. Mol Cell Biol. 2005, 25: 312-323. 10.1128\/MCB.25.1.312-323.2005.","journal-title":"Mol Cell Biol"},{"key":"1937_CR8","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1359\/jbmr.1997.12.8.1174","volume":"12","author":"C Shukunami","year":"1997","unstructured":"Shukunami C, Ishizeki K, Atsumi T, Ohta Y, Suzuki F, Hiraki Y: Cellular hypertrophy and calcification of embryonal carcinoma-derived chondrogenic cell line ATDC5 in vitro. J Bone Miner Res. 1997, 12: 1174-1188. 10.1359\/jbmr.1997.12.8.1174.","journal-title":"J Bone Miner Res"},{"key":"1937_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0922-3371(90)90079-C","volume":"30","author":"T Atsumi","year":"1990","unstructured":"Atsumi T, Miwa Y, Kimata K, Ikawa Y: A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ Dev. 1990, 30: 109-116. 10.1016\/0922-3371(90)90079-C.","journal-title":"Cell Differ Dev"},{"key":"1937_CR10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0022-2275(20)37003-6","volume":"17","author":"BE Cham","year":"1976","unstructured":"Cham BE, Knowles BR: A solvent system for delipidation of plasma or serum without protein precipitation. J Lipid Res. 1976, 17: 176-181.","journal-title":"J Lipid Res"},{"key":"1937_CR11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1089\/hyb.1991.10.595","volume":"10","author":"AS Dion","year":"1991","unstructured":"Dion AS, Smorodinsky NI, Williams CJ, Wreschner DH, Major PP, Keydar I: Recognition of peptidyl epitopes by polymorphic epithelial mucin (PEM)-specific monoclonal antibodies. Hybridoma. 1991, 10: 595-610.","journal-title":"Hybridoma"},{"key":"1937_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0009-8981(76)90061-9","volume":"66","author":"G Lust","year":"1976","unstructured":"Lust G, Seegmiller JE: A rapid, enzymatic assay for measurement of inorganic pyrophosphate in biological samples. Clin Chim Acta. 1976, 66: 241-249. 10.1016\/0009-8981(76)90061-9.","journal-title":"Clin Chim Acta"},{"key":"1937_CR13","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1002\/1529-0131(199909)42:9<1986::AID-ANR26>3.0.CO;2-O","volume":"42","author":"K Johnson","year":"1999","unstructured":"Johnson K, Vaingankar S, Chen Y, Moffa A, Goldring MB, Sano K, Jin-Hua P, Sali A, Goding J, Terkeltaub R: Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes. Arthritis Rheum. 1999, 42: 1986-1997. 10.1002\/1529-0131(199909)42:9<1986::AID-ANR26>3.0.CO;2-O.","journal-title":"Arthritis Rheum"},{"key":"1937_CR14","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/clinchem\/29.5.751","volume":"29","author":"NW Tietz","year":"1983","unstructured":"Tietz NW, Burtis CA, Duncan P, Ervin K, Petitclerc CJ, Rinker AD, Shuey D, Zygowicz ER: A reference method for measurement of alkaline phosphatase activity in human serum. Clin Chem. 1983, 29: 751-761.","journal-title":"Clin Chem"},{"key":"1937_CR15","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1086\/343054","volume":"71","author":"A Pendleton","year":"2002","unstructured":"Pendleton A, Johnson MD, Hughes A, Gurley KA, Ho AM, Doherty M, Dixey J, Gillet P, Loeuille D, McGrath R, et al: Mutations in ANKH cause chondrocalcinosis. Am J Hum Genet. 2002, 71: 933-940. 10.1086\/343054.","journal-title":"Am J Hum Genet"},{"key":"1937_CR16","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1002\/art.11133","volume":"48","author":"CJ Williams","year":"2003","unstructured":"Williams CJ, Pendleton A, Bonavita G, Reginato AJ, Hughes AE, Peariso S, Doherty M, McCarty DJ, Ryan LM: Mutations in the amino terminus of ANKH in two US families with calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum. 2003, 48: 2627-2631. 10.1002\/art.11133.","journal-title":"Arthritis Rheum"},{"key":"1937_CR17","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1086\/343053","volume":"71","author":"CJ Williams","year":"2002","unstructured":"Williams CJ, Zhang Y, Timms A, Bonavita G, Caeiro F, Broxholme J, Cuthbertson J, Jones Y, Marchegiani R, Reginato A, et al: Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH. Am J Hum Genet. 2002, 71: 985-991. 10.1086\/343053.","journal-title":"Am J Hum Genet"},{"key":"1937_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/88236","volume":"28","author":"P Nurnberg","year":"2001","unstructured":"Nurnberg P, Thiele H, Chandler D, Hohne W, Cunningham ML, Ritter H, Leschik G, Uhlmann K, Mischung C, Harrop K, et al: Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. Nat Genet. 2001, 28: 37-41. 10.1038\/88236.","journal-title":"Nat Genet"},{"key":"1937_CR19","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1086\/320612","volume":"68","author":"E Reichenberger","year":"2001","unstructured":"Reichenberger E, Tiziani V, Watanabe S, Park L, Uek Yi, Santanna C, Baur ST, Shiang R, Grange DK, Beighton P, et al: Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Genet. 2001, 68: 1321-1326. 10.1086\/320612.","journal-title":"Am J Hum Genet"},{"key":"1937_CR20","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.2001.281.1.C1","volume":"281","author":"RA Terkeltaub","year":"2001","unstructured":"Terkeltaub RA: Inorganic pyrophosphate generation and disposition in pathophysiology [review, 128 refs]. Am J Physiol Cell Physiol. 2001, 281: C1-C11.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1937_CR21","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1002\/1529-0131(200012)43:12<2703::AID-ANR10>3.0.CO;2-Y","volume":"43","author":"J Hirose","year":"2000","unstructured":"Hirose J, Masuda I, Ryan LM: Expression of cartilage intermediate layer protein\/nucleotide pyrophosphohydrolase parallels the production of extracellular inorganic pyrophosphate in response to growth factors and with aging. Arthritis Rheum. 2000, 43: 2703-2711. 10.1002\/1529-0131(200012)43:12<2703::AID-ANR10>3.0.CO;2-Y.","journal-title":"Arthritis Rheum"},{"key":"1937_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1063-4584(05)80065-2","volume":"2","author":"U Olmez","year":"1994","unstructured":"Olmez U, Ryan LM, Kurup IV, Rosenthal AK: Insulin-like growth factor-1 suppresses pyrophosphate elaboration by transforming growth factor beta1-stimulated chondrocytes and cartilage. Osteoarthritis Cartilage. 1994, 2: 149-154. 10.1016\/S1063-4584(05)80065-2.","journal-title":"Osteoarthritis Cartilage"},{"key":"1937_CR23","doi-asserted-by":"publisher","first-page":"9445","DOI":"10.1073\/pnas.142063399","volume":"99","author":"L Hessle","year":"2002","unstructured":"Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, Terkeltaub R, Millan JL: Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci USA. 2002, 99: 9445-9449. 10.1073\/pnas.142063399.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1937_CR24","doi-asserted-by":"crossref","first-page":"R1365","DOI":"10.1152\/ajpregu.2000.279.4.R1365","volume":"279","author":"KA Johnson","year":"2000","unstructured":"Johnson KA, Hessle L, Vaingankar S, Wennberg C, Mauro S, Narisawa S, Goding JW, Sano K, Millan JL, Terkeltaub R: Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. Am J Physiol Regul Integr Comp Physiol. 2000, 279: R1365-R1377.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1937_CR25","first-page":"395","volume":"26","author":"AK Rosenthal","year":"1999","unstructured":"Rosenthal AK, Henry LA: Thyroid hormones induce features of the hypertrophic phenotype and stimulate correlates of CPPD crystal formation in articular chondrocytes. J Rheumatol. 1999, 26: 395-401.","journal-title":"J Rheumatol"},{"key":"1937_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1006\/excr.1993.1209","volume":"207","author":"M Iwamoto","year":"1993","unstructured":"Iwamoto M, Shapiro IM, Yagami K, Boskey AL, Leboy PS, Adams SL, Pacifici M: Retinoic acid induces rapid mineralization and expression of mineralization-related genes in chondrocytes. Exp Cell Res. 1993, 207: 413-420. 10.1006\/excr.1993.1209.","journal-title":"Exp Cell Res"},{"key":"1937_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/jcb.240520212","volume":"52","author":"JB Lian","year":"1993","unstructured":"Lian JB, McKee MD, Todd AM, Gerstenfeld LC: Induction of bone-related proteins, osteocalcin and osteopontin, and their matrix ultrastructural localization with development of chondrocyte hypertrophy in vitro. J Cell Biochem. 1993, 52: 206-219. 10.1002\/jcb.240520212.","journal-title":"J Cell Biochem"},{"key":"1937_CR28","doi-asserted-by":"publisher","first-page":"8695","DOI":"10.1074\/jbc.275.12.8695","volume":"275","author":"H Enomoto","year":"2000","unstructured":"Enomoto H, Enomoto-Iwamoto M, Iwamoto M, Nomura S, Himeno M, Kitamura Y, Kishimoto T, Komori T: Cbfa1 is a positive regulatory factor in chondrocyte maturation. J Biol Chem. 2000, 275: 8695-8702. 10.1074\/jbc.275.12.8695.","journal-title":"J Biol Chem"},{"key":"1937_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0925-4773(98)00210-X","volume":"80","author":"IS Kim","year":"1999","unstructured":"Kim IS, Otto F, Zabel B, Mundlos S: Regulation of chondrocyte differentiation by Cbfa1. Mech Dev. 1999, 80: 159-170. 10.1016\/S0925-4773(98)00210-X.","journal-title":"Mech Dev"},{"key":"1937_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/01.bor.0000209432.36355.6e","volume":"18","author":"R Zaka","year":"2006","unstructured":"Zaka R, Williams CJ: Role of the progressive ankylosis gene in cartilage mineralization. Curr Opin Rheumatol. 2006, 18: 181-186. 10.1097\/01.bor.0000209432.36355.6e.","journal-title":"Curr Opin Rheumatol"},{"key":"1937_CR31","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/art.20978","volume":"52","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Johnson K, Russell G, Wordsworth P, Carr A, Terkeltaub RA, Brown MA: Association of sporadic chondrocalcinosis with a -4 basepair G to A transition in the 5' untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate. Arthritis Rheum. 2005, 52: 1110-1117. 10.1002\/art.20978.","journal-title":"Arthritis Rheum"},{"key":"1937_CR32","first-page":"345","volume":"8","author":"T Yoshimatu","year":"2001","unstructured":"Yoshimatu T, Saitoh A, Ryu JN, Shima D, Hand H, Hiramoto M, Kawakami Y, Aizawa S: Characterization of immortalized human chondrocytes originated from osteoarthritic cartilage. Int J Mol Med. 2001, 8: 345-351.","journal-title":"Int J Mol Med"},{"key":"1937_CR33","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0934-8832(11)80235-0","volume":"11","author":"LM Ryan","year":"1991","unstructured":"Ryan LM, Kurup I, Cheung HS: Stimulation of cartilage inorganic pyrophosphate elaboration by ascorbate. Matrix. 1991, 11: 276-281.","journal-title":"Matrix"},{"key":"1937_CR34","first-page":"S248","volume":"50","author":"A Bianchi","year":"2004","unstructured":"Bianchi A, Perrey J, Morin S, Moulin D, Koufany M, Gillet P, Loeuille D, Terlain B, Jouzeau J-Y, Netter P: Growth factors and cytokines modulate Progressive ankylosis gene expression in rat chondrocytes \u2013 Ank induction by TGFbeta depends on PKC pathway and ePPi level [abstract]. Arthritis Rheum. 2004, 50: S248-","journal-title":"Arthritis Rheum"},{"key":"1937_CR35","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1359\/jbmr.2003.18.6.994","volume":"18","author":"K Johnson","year":"2003","unstructured":"Johnson K, Goding J, Van Etten D, Sali A, Hsu SI, Farley D, Krug H, Hessle L, Millan JL, Terkeltaub R: Linked deficiencies in extracellular PPi and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression. J Bone Miner Res. 2003, 18: 994-1004. 10.1359\/jbmr.2003.18.6.994.","journal-title":"J Bone Miner Res"},{"key":"1937_CR36","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0002-9440(10)63208-7","volume":"164","author":"D Harmey","year":"2004","unstructured":"Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Millan JL: Concerted regulation of inorganic pyrophosphate and osteopontin by Akp2, Enpp1, and Ank. Am J Pathol. 2004, 164: 1199-1209.","journal-title":"Am J Pathol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar2072\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:48:06Z","timestamp":1728384486000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar2072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,26]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2006,12]]}},"alternative-id":["1937"],"URL":"https:\/\/doi.org\/10.1186\/ar2072","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,26]]},"assertion":[{"value":"10 August 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R164"}}